Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of Lu AF11167 in
patients with schizophrenia following various repeated dosing regimens of Lu AF11167 (alone
or as added treatment to risperidone).